ethamolin has been researched along with Skin-Neoplasms* in 2 studies
2 other study(ies) available for ethamolin and Skin-Neoplasms
Article | Year |
---|---|
Sclerotherapy of hemangioma with late involution.
Most cutaneous hemangiomas involute spontaneously. However, the lesion existing on the face poses a cosmetic problem during the waiting period for involution.. Hemangioma showing late involution was treated by local injection of monoethanolamine oleate solution.. The lesion flattened and was excised serially.. Sclerotherapy with monoethanolamine oleate can shorten the waiting period for involution and can decrease the risk of psychosocial trauma. Moreover, it provides good preparation for further surgery. Such sclerotherapy is effective in the treatment of hemangioma with late involution. Topics: Dermatologic Agents; Female; Hemangioma; Humans; Infant; Injections, Intralesional; Oleic Acid; Oleic Acids; Sclerotherapy; Skin Neoplasms | 2003 |
Treatment of pyogenic granuloma with a sclerosing agent.
Pyogenic granulomas have been treated by cryosurgery, curettage, electrodesiccation, chemical cauterization, and laser surgery. The therapeutic effects of these conservative treatments are limited, however.. In this study, the efficacy of a sclerosing agent (monoethanolamine oleate) was evaluated for the treatment of pyogenic granuloma.. Pyogenic granuloma was treated by local injection of the monoethanolamine oleate solution in nine patients who were from 1 to 57 years of age (median 18 years). The treatment effect was determined by physical examination.. All lesions were removed completely with no recurrence, and scars were inconspicuous in all cases. Complications occurred in only one patient who complained of pain due to an avoidable injection of excess solution.. Sclerotherapy with monoethanolamine oleate is effective in the treatment of pyogenic granuloma and offers an alternative to conventional methods in cases for which conservative treatment is preferable. Topics: Adolescent; Adult; Child; Child, Preschool; Face; Female; Fingers; Granuloma, Pyogenic; Humans; Infant; Injections, Intralesional; Male; Middle Aged; Oleic Acid; Oleic Acids; Sclerosing Solutions; Skin Neoplasms; Tongue; Treatment Outcome | 2001 |